Evidence map›Paper›PMID 28172488›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2017

Extrahepatic Complications of Hepatitis C Virus Infection in HIV and the Impact of Successful Antiviral Treatment.

Vincent Lo Re

Registry-linked trialAbstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03365635 ("Real World" Administration of Zepatier), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03365635 phase4completednot on this mapstarted 2019, after this paper: background citation

"Real World" Administration of Zepatier (Grazoprevir Plus Elvasvir) in Chronic Hemodialysis Patients With Hepatitis C Infection. Strategies for Identification of Patients, Insurance Approval, Treatment , and Laboratory Monitoring

TypeinterventionalSponsorUniversity of PennsylvaniaRan2019 to 2020Enrolled6ConditionsHepatitis C, Hemodialysis, Nosocomial InfectionArmsElbasvir 50 MG / Grazoprevir 100 MG [Zepatier]
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Vincent Lo ReDivision of Infectious Diseases, Department of Medicine, Penn Center for AIDS Research, Penn Center for Viral Hepatitis

Funding

(PQ4)HIV and Aging Mechanisms for Hepatocellular CancerR01CA206465 · NCI · YALE UNIVERSITY · PI JUSTICE, AMY CAROLINE, LO RE, VINCENT · 2016 to 2020
$2.5M
Risk of Liver Complications with HBV and HIV Viremia During Tenofovir-Based ARTR21AI124868 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI LO RE, VINCENT · 2016 to 2017
$454k
NCI NIH HHS R01 CA206465NIAID NIH HHS R21 AI124868
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HepacivirusHepatitis CAntiviral AgentsCohort StudiesHIVHumansAntiviral Agents

Identifiers

PMID28172488
PMCPMC5850615

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.